Skip to main content

Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on Monday, Jan. 12, 2026.

Bernard Zovighian, chief executive officer, is scheduled to present at 11:15 a.m. PT. Scott Ullem, chief financial officer, will also participate in the conference. A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/, with an archived version accessible later the same day.

About Edwards Lifesciences

Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. Discover more at www.edwards.com and follow us on LinkedIn, Facebook, Instagram and YouTube.

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  209.71
+4.85 (2.37%)
AAPL  262.31
+1.73 (0.66%)
AMD  203.27
-0.10 (-0.05%)
BAC  52.57
-0.20 (-0.38%)
GOOG  314.30
+10.74 (3.54%)
META  655.95
+11.17 (1.73%)
MSFT  398.08
-0.38 (-0.10%)
NVDA  189.20
+1.30 (0.69%)
ORCL  152.36
-4.18 (-2.67%)
TSLA  411.58
-0.13 (-0.03%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.